Masaaki Kitahara Selected Research

Masaaki Kitahara Research Topics

Disease

16	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2007
13	Neoplasms (Cancer) 01/2022 - 01/2007
3	Fibrosis (Cirrhosis) 09/2020 - 10/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 04/2019
2	Melanoma (Melanoma, Malignant) 10/2020 - 11/2018
2	Thrombosis (Thrombus) 09/2020 - 12/2019
2	Non-alcoholic Fatty Liver Disease 07/2020 - 01/2018
1	Hypophosphatemia 02/2021
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Tumor Lysis Syndrome 10/2020
1	Residual Neoplasm 07/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Inflammation (Inflammations) 10/2019
1	Alcoholic Fatty Liver 10/2019
1	Neoplasms, Cystic, Mucinous, and Serous 04/2019
1	Chronic Pancreatitis 04/2019
1	Renal Insufficiency (Renal Failure) 02/2019
1	Reinfection 02/2019
1	Infections 01/2019
1	Cholangiocarcinoma 11/2018
1	Drug-Related Side Effects and Adverse Reactions 12/2015
1	Liver Neoplasms (Liver Cancer) 04/2014
1	Meniere Disease (Menieres Disease) 05/2008

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2022 - 01/2016
6	Peptides (Polypeptides)IBA 01/2022 - 08/2015
3	Sorafenib (BAY 43-9006)FDA Link 02/2021 - 11/2014
3	EpitopesIBA 01/2020 - 01/2018
2	Protein Subunit VaccinesIBA 01/2022 - 12/2015
2	Fetal Proteins (Fetoprotein)IBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 04/2019 - 01/2007
2	CytokinesIBA 01/2019 - 01/2007
2	squamous cell carcinoma-related antigenIBA 11/2018 - 01/2017
2	Multidrug Resistance-Associated ProteinsIBA 11/2018 - 12/2015
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2015
1	lenvatinibIBA 02/2021
1	regorafenibIBA 02/2021
1	NivolumabIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	AnticoagulantsIBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020
1	danaparoid (Orgaran)FDA Link 12/2019
1	palmitoleic acidIBA 10/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	paritaprevirIBA 02/2019
1	Ritonavir (Norvir)FDA Link 02/2019
1	ombitasvirIBA 02/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	EnzymesIBA 11/2018
1	InterferonsIBA 11/2018
1	Carcinoembryonic AntigenIBA 11/2018
1	KinesinsIBA 11/2018
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2018
1	GlypicansIBA 11/2018
1	Mucin 5ACIBA 11/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2014
1	HLA-DR Antigens (HLA-DR)IBA 08/2013
1	SteroidsIBA 05/2008
1	Thymidine KinaseIBA 01/2007
1	ChemokinesIBA 01/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2007
1	Immunomodulating AgentsIBA 01/2007
1	Interleukin-18 (Interleukin 18)IBA 01/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2007
1	Interleukin-12 (IL 12)IBA 01/2007

Therapy/Procedure

7	Immunotherapy 01/2021 - 08/2014
5	Therapeutics 02/2021 - 04/2014
4	Drug Therapy (Chemotherapy) 01/2021 - 11/2014
2	Radiofrequency Ablation 07/2020 - 04/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Liver Transplantation 02/2019